Popular Articles

New Pre-Clinical Data On OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting In Brain Tissue
OmniGuide, Inc., the developer of the first and only flexible CO2 laser fiber based on breakthrough photonic bandgap technology, announced the results of a pre-clinical study comparing the Company"s fiber scalpels to conventional incision methods in neurosurgery. In the study, surgeons from the Barrow Neurological Institute reported that careful studies of incisions produced in live brain tissue with fiber delivered CO2 laser radiation produced precise cuts while minimally effecting adjacent brain tissue when compared with a widely used reference technique. The study, led by Drs. Mark Preul, Robert W. Ryan, and Robert Spetzler of the Neurosurgery Research Laboratory, Barrow Neurological Institute, in Phoenix, Arizona, was presented at the annual conference of the American Academy of Neurological Surgeons in San Diego, California.

UK Young People Want Better Information On Sexual Health
83% of young people surveyed by UNICEF UK and Terence Higgins Trust say they need a sexual health information service similar to the Government"s "Talk to Frank" drugs service.
News of the day
Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression Of Structural Joint Damage In Rheumatoid Arthritis Patients
One-year data from the two-year Phase III LITHE (TociLIzumab Safety and THE Prevention of Structural Joint Damage) study demonstrated that a greater proportion of rheumatoid arthritis (RA) patients treated with ACTEMRA(R) (tocilizumab), a novel interleukin-6 (IL-6) receptor inhibitor, in combination with methotrexate, experienced a significant inhibition in the progression of structural joint damage compared with patients treated with methotrexate alone. These data will be presented at the 10th Annual Congress of the European League Against Rheumatism (EULAR) in Copenhagen, Denmark, along with additional studies that support the use of ACTEMRA as a long-term treatment option for patients with moderately to severely active RA.
Health Insurance

Basic Facts And Statistics About Lupus

In response to a recent increase in media interest in lupus, the Lupus Foundation of America (LFA) is providing a fact sheet about the disease. What is lupus? Lupus is a chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue damage to virtually any tissue or organ in the body. Its health effects include skin lesions, heart attacks, strokes, seizures, miscarriages, and organ failure. What are the symptoms of lupus? The most common symptoms include severe joint pain and swelling, overwhelming fatigue, fevers, skin rashes, pain in the chest on deep breathing, hair loss, and sensitivity to ultraviolet light. Symptoms come and go and can change over time, and range from mild to life-threatening. What are the different forms of lupus? There are several forms of lupus, the most common being cutaneous and systemic. Cutaneous lupus is limited to the skin and is often identified by a rash or skin lesions that appears on sun-exposed areas of the body, such as the scalp, face, neck, hands, and arms. Cutaneous lupus accounts for approximately 10% of all cases. Systemic lupus is usually more severe and can affect almost any organ or system of the body, including the skin, joints, lungs, kidneys, heart, nervous system, and brain. Approximately 70% of lupus cases are systemic. In about half of these cases, a major organ will be affected. Who develops lupus? Ninety percent of the people with lupus are women. The disease develops most often between the ages of 15 and 44, although males and females of any age can be affected. Lupus is two to three times more common among African Americans, Hispanics/Latinos, Native Americans, and Asians, than among Caucasians. Based on several nationwide telephone surveys, the LFA estimates that approximately 1,500,000 Americans have a form of the disease. What causes lupus? The exact causes of lupus are unknown. Researchers believe that certain environmental factors play a role in triggering the disease in people who are genetically susceptible to developing lupus. These environmental triggers include infections, ultraviolet light, extreme stress, antibiotics and certain other drugs, and hormonal changes. Hormonal factors may explain why lupus occurs more frequently in females than in males. Despite some statements in the media recently, there is no known connection between childhood abuse and lupus. Lupus is NOT infectious, rare, or cancerous. It is not related to or like HIV/AIDS. About the Lupus Foundation of America The LFA is the foremost national nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. Founded in 1977, the LFA has a nationwide network of nearly 300 chapters and support groups and operates programs of research, education, and advocacy. Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Lupus Foundation of America


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):